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DISCUSSION

INTRODUCTION

Heroin and drug related overdoses have increased by over 20% annually
since 2014 in the state of Pennsylvania. Fueled by addiction to prescription
drugs, addicts have turned to alternative methods to get high. According
to a report in the Annals of Emergency Medicine, there has been a 10-fold
increase in internet posting regarding the abusive potential of loperamide.
70% of postings discussed loperamide for opiate withdrawal, while
1
approximately 25% focused on using loperamide to get high. We present a
case of a patient who abused loperamide with dangerous consequences.

Loperamide is an opioid derivative and common over-the-counter antidiarrheal drug. At
high doses, loperamide crosses the blood-brain barrier and reaches opioid receptors in
the brain, leading to central opiate effects including euphoria and respiratory depression.
Approximately 40% of the drug is absorbed into the bloodstream after oral administration.
The drug is metabolized to inactive products and is eliminated through both the urine and
the feces.
Drug-induced TdP typically results from the development of early afterdepolarizations and
triggered activities from prolonged repolarization. This is usually caused by a ventricular
2
premature beat falls on a prolonged repolarization cycle.
The mechanism of QTc prolongation due to loperamide is unclear. QTc prolongation related
to synthetic opioids is due to blockade of the cardiac ‘human ether-a-go-go’ (hERG)
2
potassium channel. Loperamide may block hERG, leading to prolonged QT.
The half-life of loperamide is 9-14 hours. We maintained the patient on isoproterenol to
maintain a heart rate of >80. No further episodes of torsades were seen after admission.
Loperamide is categorized as a QTc-prolonging drug in the public registry http://www.
crediblemeds.org. In June 2016, the FDA issued a warning regarding loperamide abusive
potential and cardiac toxicity.
In patients with unexplained syncope, QT prolongation, and malignant ventricular
arrhythmias, loperamide abuse should be considered in the differential diagnosis.

CASE REPORT

A 39 year old female with a history of opiate abuse and hepatitis C, presented
to the ER after witnessed syncope and tonic-clonic seizure like activity.
In the emergency department, the patient had another seizure like episode and
was found to have torsades de pointes on telemetry. An EKG revealed sinus
bradycardia with QTc of nearly 700ms. The patient reported recreational
loperamide abuse, taking 100 tablets daily for the past 3 months. The patient
was admitted to the cardiac intensive care unit for hemodynamic monitoring.
Isoproterenol infusion was initiated. Heart rate was maintained greater than
80 BPM. Admission potassium was 3.0 and magnesium 1.7. Electrolyte levels
were closely monitored and repleted.
An echocardiogram revealed hyperdynamic LV function, without any chamber
enlargement or valvular disease. The patient remained on isoproterenol drip
for 96 hours. EKGs were routinely performed and isoproterenol was eventually
weaned off. No subsequent episodes of torsades were noted. On the day of
discharge, the QTc was 466ms. The patient was discharged with instructions
to avoid QT prolonging agents and avoid any further use of loperamide.

Admission ECG

Discharge ECG
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Hospital Day

Loperamide Level

Desmethylloperamide

1

76 ng/mL

630 ng/mL

2

30 ng/mL
9.3 ng/mL
Not detected
Not detected
Not detected
Not detected

350 ng/mL
230 ng/mL
120 ng/mL
74 ng/mL
47 ng/mL
27 ng/mL
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4
5
6
7

2.	Mukarram, O. (2016, January 2). Loperamide Induced Torsades de Pointes: A Case Report and Review of the Literature. Retrieved November 9,
2016, from https://www.hindawi.com/journals/crim/2016/4061980
© 2016 Lehigh Valley Health Network

